- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Robert Gabbay Discusses ADA's Efforts to Address Effect of Diabetes on Kidney Disease
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association (ADA), describes the ADA's efforts to elevate the conversation about the impact of diabetes on kidney disease.
Most people who have chronic kidney disease do not know they have it and are not getting screened, said Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association.
Transcript
The introduction of newer therapies to prevent renal decline has brought attention to the need for improved monitoring of patients with diabetes. Can you discuss ADA’s efforts in this area?
The American Diabetes Association has been really concerned about the impact of diabetes on renal disease for some time. Diabetes is the leading cause for end-stage renal disease in the US, and so it is a major contributor to a host of morbidity and mortality associated with kidney disease. The unfortunate thing is that most people are not aware that they have chronic kidney disease and are not being screened. We are about to launch a national effort to really elevate the conversation around kidney disease. And stay tuned in the coming months, we'll be announcing some exciting work that will expand on the work we're already doing in this area, but we really think the time has come to tackle this in a big way.
Weight Fluctuation Threatens Kidney Health in Type 1 Diabetes
February 4th 2025Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which interested investigators in potential links between these weight fluctuations and increased risk of renal events among a population with type 1 diabetes.
Read More
More Needs to Be Done to Reduce Racial Disparities in Home Dialysis
March 24th 2023On this episode of Managed Care Cast, we speak with Virginia Wang, PhD, and Matthew L. Maciejewski, PhD, who talk about their recent study on racial disparities in home dialysis, and what more needs to be done to increase uptake and reduce disparities in home dialysis for non-White patients.
Listen
Transforming Kidney Care: Policy, Risk Stratification, and Collaborative Models
December 12th 2024Experts at a recent Institute for Value-Based Medicine event emphasized the importance of early intervention, policy innovation, and proactive collaboration to transform the management of kidney disease and optimize patient outcomes.
Read More
